Cosmo Pharmaceuticals Full Year 2024 Earnings: In Line With Expectations

By Yahoo! Finance   |   1 month ago
Cosmo Pharmaceuticals Full Year 2024 Earnings: In Line With Expectations

Profit margin increased to 50% from a net loss in FY 2023 due to higher revenue. Revenue met analyst estimates, and EPS was in line with expectations. Future revenue is forecasted to grow at 22% p.a. over the next 3 years.

Read More

Did you find this insightful?